Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Smoking Cessation × Bupropion × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Overweight 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Obesity 1 Neoplasms, Second Primary 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Behavior, Addictive 1

Interventions

Aspirin 2 sulforaphane 1 polyphenon E 1 cytisine 1 Varenicline 1 Tomography, X-Ray Computed 1 Tomography 1 Tobacco Use Cessation Devices 1 Tea 1 Spirometry 1 Secondary Prevention 1 Positron-Emission Tomography 1 Positron Emission Tomography Computed Tomography 1 Nicotine Chewing Gum 1 Hematologic Tests 1 Fluorodeoxyglucose F18 1 Exercise 1 Diet Therapy 1 Diagnostic Imaging 1 Bupropion 1 4-(3-fluoropropyl)glutamic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡